Spend time with your patients, discussing both the risks and benefits of a potential coronavirus disease 2019 vaccine, emphasized Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.
Spend time with your patients, discussing both the risks and benefits of a potential coronavirus disease (COVID) 2019 vaccine; talk with them about their fears; and perhaps most important, be patient and transparent, emphasized Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.
Transcript
What can be said to assuage the fears people have about a coronavirus vaccine?
I think many of these fears are very common about any sort of clinical trial, whether it be a COVID vaccine or even trials for new cancer therapies. I think people inherently have fears, because it's a clinical trial and something that's new. And so I think what we can say as health care providers to assuage our patients’ fears is just basically to spend the time answering their questions, provide as much transparent information as we have, as possible, about the process of development, about the potential side effects.
And I think, again, we just need to be patient with people, as they're able to state their fears and we're able to answer their questions and patiently work with them very transparently, and at the level that they understand. Don't talk above their heads. Tell them exactly what's going on.
Talking about risks and benefits is another really important part of this. As you mentioned, there are definitely people that are disproportionately affected, and persons of color, and I think that's something that we should discuss with our patients when applicable.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Chronic Respiratory Diseases Linked to Other Noncommunicable Diseases in Vulnerable Countries
August 4th 2025Despite their devastating global impact, chronic respiratory diseases remain a hidden threat in low- and middle-income countries, often going undiagnosed in adults who are already battling other noncommunicable diseases.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
RSV's Impact on Heart Health Emphasizes Broader Risks, Vaccination Importance for Older Adults
July 23rd 2025Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in older adults, underscoring the need for vaccination in this population regardless of their preexisting health conditions.
Read More